Abstract
Pathological variants in genes encoding calmodulin are associated with severe clinical presentations, including recurrent ventricular fibrillation and sudden death. Beta-receptor antagonists (beta-blockers) and sodium-channel antagonists have been reported as pharmacotherapies...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have